
BioNet (CEO Min Steven Sang-won) announced that it will participate in ‘Arab Health 2025’ to be held in Dubai, United Arab Emirates from the 27th to the 30th.
'Arab Health' is the largest international medical equipment exhibition in the Middle East, and this year marks its 50th anniversary. This exhibition is an important venue where hospital staff and industry experts from around the world, beyond the Middle East, participate to share the latest medical trends, and this year, the organizer estimates that approximately 3,800 companies from 180 countries will participate.
At this exhibition, BioNet plans to actively promote its technological prowess and market competitiveness by introducing its representative products, including ▲patient monitoring devices 'Brio X70/X50/X30' (hereinafter Brio X Series), ▲wireless ultrasound scanner 'SonoMe', ▲electrocardiographs 'Cardio Q70/Q50', and ▲wireless vital sign sensor for animals 'O'pet Curv'.
In addition, we plan to focus on discovering potential customers by meeting with buyers and industry professionals who visit our booth, focusing on major products that have acquired US FDA and European CE certifications. We will also hold a seminar on product solutions for existing customers at the 'Ibis One Central Hotel' during the event.
The seminar will introduce patient monitoring devices, electrocardiographs, and veterinary product solutions, including 'SonoMe', and in particular, demonstrate the functions of the wireless ultrasound scanner 'SonoMe' and emphasize the excellence of the product.
“Participating in Arab Health 2025 is a great opportunity to promote Bionet’s excellent solutions to healthcare professionals in the Middle East and globally and secure new partnerships,” said Min Steven Sang-won, CEO of Bionet. “In order to respond to the rapidly growing Middle Eastern healthcare market, we will carry out more aggressive sales and marketing activities to strengthen existing customer relationships and secure new customers.”
Meanwhile, BioNet Co., Ltd. has already obtained US FDA and European CE certification for its 'SonoMe' and 'Cardio Q70/Q50' products, and is also expanding into the global market by obtaining European CE certification for its flagship product, the patient monitoring device 'Brio X Series'.
- See more related articles
You must be logged in to post a comment.